This Lumentum Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Benzinga·11/18 13:26
Share
Listen to the news
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
BTIG analyst Marie Thibault initiated coverage on Kestra Medical Technologies Ltd(NASDAQ:KMTS) with a Buy rating and announced a price target of $32. Kestra Medical Techs shares closed at $25.10 on Monday. See how other analysts view this stock.
Freedom Capital Markets analyst David Silver initiated coverage on Innospec Inc(NASDAQ:IOSP) with a Buy rating and announced a price target of $93. Innospec shares closed at $72.23 on Monday. See how other analysts view this stock.
UBS analyst Michael Goldsmith initiated coverage on Sabra Health Care REIT Inc(NASDAQ:SBRA) with a Neutral rating and announced a price target of $20. Sabra Health Care shares closed at $18.59 on Monday. See how other analysts view this stock.
Mizuho analyst Vijay Rakesh initiated coverage on Lumentum Holdings Inc(NASDAQ:LITE) with an Outperform rating and announced a price target of $290. Lumentum closed at $242.07 on Monday. See how other analysts view this stock.
William Blair analyst Neal Dingmann initiated coverage on Kodiak Gas Services Inc(NYSE:KGS) with an Outperform rating. Kodiak Gas Services shares closed at $32.95 on Monday. See how other analysts view this stock.
Considering buying LITE stock? Here’s what analysts think:
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.